These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 159142)

  • 101. Effects of the cessation of training on left ventricular function in the racing greyhound. Serial studies in a model of cardiac hypertrophy.
    Pape LA; Rippe JM; Walker WS; Weiner BH; Ockene IS; Paraskos JA; Alpert JS
    Basic Res Cardiol; 1984; 79(1):98-109. PubMed ID: 6233966
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Cardiac conditioning ameliorates cardiac dysfunction associated with renal hypertension in rats.
    Schaible TF; Ciambrone GJ; Capasso JM; Scheuer J
    J Clin Invest; 1984 Apr; 73(4):1086-94. PubMed ID: 6231311
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical, and mechanical parameters.
    Thiedemann KU; Holubarsch C; Medugorac I; Jacob R
    Basic Res Cardiol; 1983; 78(2):140-55. PubMed ID: 6223618
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Myocardial energy metabolism in the hypertrophied hearts of spontaneously hypertensive rats.
    Shimamoto N; Goto N; Tanabe M; Imamoto T; Fujiwara S; Hirata M
    Basic Res Cardiol; 1982; 77(4):359-7. PubMed ID: 6216880
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Postoperative thallium-201 myocardial images. Evidence of regression of right ventricular hypertrophy in man.
    Yamazaki H; Tsugu T; Handa S; Takagi Y; Ohsuzu F; Kondo M; Kubo A; Inoue T; Nakamura Y
    Br Heart J; 1982 Oct; 48(4):372-6. PubMed ID: 6215051
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Pathogenesis of cardiac hypertrophy in iron deficiency anaemia: the role of noradrenaline.
    Rossi MA; Carillo SV
    Br J Exp Pathol; 1982 Jun; 63(3):269-77. PubMed ID: 6212077
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Energetic changes of myocardium as an adaptation to chronic hemodynamic overload and thyroid gland activity.
    Holubarsch C; Litten RZ; Mulieri LA; Alpert NR
    Basic Res Cardiol; 1985; 80(6):582-93. PubMed ID: 4091775
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Redistribution of glucose uptake by chronic exercise, measured in isolated perfused rat hearts.
    Kainulainen H; Takala TE; Hassinen IE; Vihko V
    Pflugers Arch; 1985 Mar; 403(3):296-300. PubMed ID: 3991333
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.
    Dahlöf B
    Drugs; 1988; 35 Suppl 5():6-26. PubMed ID: 2975216
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Propranolol and thyroxine-induced hypertrophic rabbit hearts: effect on heart size and regional O2 supply/consumption variables.
    Grover GJ; Houghton JM; Weiss HR
    Basic Res Cardiol; 1988; 83(3):268-76. PubMed ID: 2970840
    [TBL] [Abstract][Full Text] [Related]  

  • 111. A biphasic change in contractile proteins during the development of cardiac hypertrophy in pigs.
    Elimban V; Dhalla KS; Panagia V; Singal PK; Dhalla NS
    Basic Res Cardiol; 1987; 82(1):1-8. PubMed ID: 2954533
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals.
    Izumo S; Lompré AM; Matsuoka R; Koren G; Schwartz K; Nadal-Ginard B; Mahdavi V
    J Clin Invest; 1987 Mar; 79(3):970-7. PubMed ID: 2950137
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart.
    Klein I; Hong C
    J Clin Invest; 1986 May; 77(5):1694-8. PubMed ID: 2939104
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Angiotensin and the remodelling of the myocardium.
    Weber KT; Janicki JS
    Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):141S-149S; discussion 149S-150S. PubMed ID: 2690905
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Left ventricular dilatation and failure post-myocardial infarction: pathophysiology and possible pharmacologic interventions.
    Firth BG; Dunnmon PM
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1363-74. PubMed ID: 2149059
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Chronic hemodynamic unloading regulates the morphologic development of newborn mouse hearts transplanted into the ear of isogeneic adult mice.
    Rossi MA
    Am J Pathol; 1992 Jul; 141(1):183-91. PubMed ID: 1632462
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The cardiac hypertrophy process. Analyses of factors determining pathological vs. physiological development.
    Wikman-Coffelt J; Parmley WW; Mason DT
    Circ Res; 1979 Dec; 45(6):697-707. PubMed ID: 159142
    [No Abstract]   [Full Text] [Related]  

  • 118. Recovery of myosin ATPase after relief of pressure-overload hypertrophy and failure.
    Carey RA; Bove AA; Coulson RL; Spann JF
    Am J Physiol; 1978 Jun; 234(6):H711-7. PubMed ID: 149505
    [No Abstract]   [Full Text] [Related]  

  • 119. Physiological versus pathological myocardial hypertrophy.
    Wikman-Coffelt J; Laks MM; Riemenschneider T; Mason DT
    Adv Myocardiol; 1980; 1():469-76. PubMed ID: 6446742
    [No Abstract]   [Full Text] [Related]  

  • 120. [Deterioration and improvement of cardiac hypertrophy].
    Kimata S; Kawana M; Taira A; Ishizuka H; Hirosawa K; Yazaki Y; Tsuchimochi H; Koyanagi H; Hashimoto A
    Kokyu To Junkan; 1987 Jul; 35(7):723-33. PubMed ID: 2958917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.